Patents by Inventor Kiyoshi Mori
Kiyoshi Mori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140377786Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.Type: ApplicationFiled: September 10, 2014Publication date: December 25, 2014Inventors: Jonathan Matthew BARASCH, Prasad DEVARAJAN, Thomas L. NICKOLAS, Kiyoshi MORI
-
Patent number: 8916872Abstract: A method of forming a stacked low temperature diode and related devices. At least some of the illustrative embodiments are methods comprising forming a metal interconnect disposed within an inter-layer dielectric. The metal interconnect is electrically coupled to at least one underlying integrated circuit device. A barrier layer is deposited on the metal interconnect and the inter-layer dielectric. A semiconductor layer is deposited on the barrier layer. A metal layer is deposited on the semiconductor layer. The barrier layer, the semiconductor layer, and the metal layer are patterned. A low-temperature anneal is performed to induce a reaction between the patterned metal layer and the patterned semiconductor layer. The reaction forms a silicided layer within the patterned semiconductor layer. Moreover, the reaction forms a P-N junction diode.Type: GrantFiled: July 11, 2014Date of Patent: December 23, 2014Assignee: Inoso, LLCInventors: Ziep Tran, Kiyoshi Mori, Giang Trung Dao, Michael Edward Ramon
-
Patent number: 8786130Abstract: A method of forming an electromechanical power switch for controlling power to integrated circuit (IC) devices and related devices. At least some of the illustrative embodiments are methods comprising forming at least one IC device on a front surface of a semiconductor substrate. The at least one IC device includes at least one circuit block and at least one power switch circuit. A dielectric layer is deposited on the IC device, and first and second electromechanical power switches are formed on the dielectric layer. The first power switch gates a voltage to the circuit block and the second power switch gates the voltage to the IC device. The first power switch is actuated by the power switch circuit, and the voltage to the circuit block is switched off. Alternatively, the second power switch is actuated by the power switch circuit, and the voltage to the IC device is switched off.Type: GrantFiled: August 23, 2013Date of Patent: July 22, 2014Assignee: INOSO, LLCInventors: Kiyoshi Mori, Ziep Tran, Giang T. Dao, Michael E. Ramon
-
Publication number: 20140080155Abstract: Methods of assessing the ongoing kidney status in a subject afflicted with chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in fluid samples over time. NGAL is a small secreted polypeptide that is protease resistant and consequently readily detected in the urine and serum as a result of chronic renal tubule cell injury. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.Type: ApplicationFiled: November 25, 2013Publication date: March 20, 2014Inventors: Jonathan M. Barasch, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
-
Patent number: 8580696Abstract: Systems and methods for detecting watermark formations on semiconductor wafers are described. In one embodiment, a method comprises providing a semiconductor wafer having at least one watermark sensitive region fabricated thereon, subjecting the wafer to a wet processing step, enhancing a susceptibility to detection of at least one watermark formation created on the at least one watermark sensitive region, and detecting the at least one watermark formation. In another embodiment, a method comprises growing a first oxide layer on a surface of a semiconductor wafer, patterning a watermark sensitive structure on the first oxide layer, depositing a silicon layer over the first oxide layer, doping a region of the silicon layer over the watermark sensitive structure with an impurity to create a watermark sensitive region that is prone to retaining watermark formations as result of a wet processing step, and growing a second oxide layer over the silicon layer.Type: GrantFiled: July 27, 2007Date of Patent: November 12, 2013Assignee: Abound LimitedInventors: Kiyoshi Mori, Shu Ikeda, Gabriel Gebara
-
Publication number: 20130231409Abstract: A process for producing expanded polyolefin resin particles with use as a foaming agent of water contained in an aqueous dispersion medium. The process includes dispersing polyolefin resin particles together with the aqueous dispersion medium into a closed vessel; heating the polyolefin resin particles up to or above a softening temperature of the polyolefin resin particles and pressurizing the polyolefin resin particles; and releasing the polyolefin resin particles into a zone whose pressure is lower than an internal pressure of the closed vessel. The polyolefin resin particles are composed of a polyolefin resin composition including polyolefin resin, polyvalent alcohol and a foam nucleating agent.Type: ApplicationFiled: April 11, 2013Publication date: September 5, 2013Applicant: Kaneka CorporationInventors: Jun FUKUZAWA, Takamasa IMAI, Kiyoshi MORI
-
Publication number: 20130137122Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.Type: ApplicationFiled: January 23, 2013Publication date: May 30, 2013Inventors: Jonathan M. Barasch, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
-
Publication number: 20130040312Abstract: Methods of assessing the ongoing kidney status in a subject afflicted with chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in fluid samples over time. NGAL is a small secreted polypeptide that is protease resistant and consequently readily detected in the urine and serum as a result of chronic renal tubule cell injury. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.Type: ApplicationFiled: October 12, 2012Publication date: February 14, 2013Inventors: Jonathan Matthew BARASCH, Prasad DEVARAJAN, Thomas L. NICKOLAS, Kiyoshi MORI
-
Patent number: 8247376Abstract: Use of neutrophil gelatinase-associated lipocalin (NGAL) as a therapeutic and in a method of treating, reducing, or ameliorating an injury selected from an ischemic injury, an ischemic-reperfusion injury, and a toxin-induced injury, to an organ in a patient. The invention includes administering to the patient NGAL in an amount effective to treat, reduce or ameliorate ischemic, ischemic-reperfusion, or toxin-induced injury to the organ, such as the kidney. A siderophore can be co-administered with the NGAL. The invention also relates to administering a sideophore to enhance a response to secretion of NGAL following an ischemic or toxin-induced injury to an organ in a patient.Type: GrantFiled: June 17, 2010Date of Patent: August 21, 2012Assignees: The Trustees of Columbia University, Children's Hospital Medical CenterInventors: Jonathan M. Barasch, Prasad Devarajan, Kiyoshi Mori
-
Patent number: 7966842Abstract: The refrigerator includes a vegetable compartment (107) thermally insulated by a rear partition (111), and a mist generation department (139) for atomizing a mist into the vegetable compartment (107), and the mist generation department (139) includes a atomizing electrode (135) for atomizing the mist into the vegetable compartment (107), a voltage applicator (133) for applying a voltage to the atomizing electrode (135), and a cooling pin (134) coupled to the atomizing electrode (135), in which the atomizing electrode (135) is cooled to a temperature lower than the dew point by a outlet air-duct for freezer compartment (141), and the moisture in the air is cooled to condense dew on the atomizing electrode (135), and is atomized as a mist into the vegetable compartment (107), and dew can be condensed from moisture onto the atomizing electrode (135) stably and in a simple configuration, and the freshness of the food is enhanced while the reliability of the refrigerator is enhanced.Type: GrantFiled: October 22, 2009Date of Patent: June 28, 2011Assignee: Panasonic CorporationInventors: Toyoshi Kamisako, Yoshihiro Ueda, Kazuya Nakanishi, Tadashi Adachi, Kazuyuki Hamada, Kiyotaka Tabira, Yasuyuki Okamoto, Kenichi Okabe, Masashi Yuasa, Kenichi Kakita, Kiyoshi Mori, Tosiaki Mamemoto, Katsunori Horii
-
Publication number: 20110143381Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.Type: ApplicationFiled: February 11, 2011Publication date: June 16, 2011Inventors: Jonathan Matthew Barasch, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
-
Publication number: 20100267850Abstract: Provided is a process for producing expanded polyolefin resin particles whose cells are not made nonuniform or extremely smaller as seen in conventional expanded particles, whose cell diameter and expansion ratio can be easily controlled independently, and which, when subjected to in-mold expansion molding, give in-mold expanded molded products satisfactory in fusibility and excellent in surface properties.Type: ApplicationFiled: December 3, 2008Publication date: October 21, 2010Inventors: Toru Yoshida, Jun Fukuzawa, Takamasa Imai, Kiyoshi Mori, Hiroshi Tsuneishi
-
Publication number: 20100254970Abstract: Use of neutrophil gelatinase-associated lipocalin (NGAL) as a therapeutic and in a method of treating, reducing, or ameliorating an injury selected from an ischemic injury, an ischemic-reperfusion injury, and a toxin-induced injury, to an organ in a patient. The invention includes administering to the patient NGAL in an amount effective to treat, reduce or ameliorate ischemic, ischemic-reperfusion, or toxin-induced injury to the organ, such as the kidney. A siderophore can be co-administered with the NGAL. The invention also relates to administering a sideophore to enhance a response to secretion of NGAL following an ischemic or toxin-induced injury to an organ in a patient.Type: ApplicationFiled: June 17, 2010Publication date: October 7, 2010Inventors: Jonathan M. BARASCH, Prasad Devarajan, Kiyoshi Mori
-
Publication number: 20100243767Abstract: A refrigerator includes: a storage compartment that is separated and heat-insulated from another area; an atomization device having an electrode unit that sprays mist into the storage compartment; and a protection unit that improves safety of a user.Type: ApplicationFiled: November 5, 2008Publication date: September 30, 2010Applicant: PANASONIC CORPORATIONInventors: Kiyoshi Mori, Kenichi Kakita, Tosiaki Mamemoto, Yoshihiro Ueda, Toyoshi Kamisako, Takahiro Ueno
-
Publication number: 20100236269Abstract: A refrigerator that sprays a mist using an atomization apparatus includes an atomization state determination unit that determines an atomization state of an atomization unit. An operation of the atomization unit is controlled according to a signal determined by the atomization state determination unit. Thus, an appropriate amount of mist spray is performed according to the atomization state, so that improved spray accuracy can be attained.Type: ApplicationFiled: November 5, 2008Publication date: September 23, 2010Applicant: PANASONIC CORPORATIONInventors: Tosiaki Mamemoto, Toyoshi Kamisako, Yoshihiro Ueda, Katsunori Horii, Kenichi Kakita, Tadashi Adachi, Kahoru Tsujimoto, Kiyoshi Mori
-
Publication number: 20100234765Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.Type: ApplicationFiled: May 21, 2010Publication date: September 16, 2010Inventors: Jonathan Matthew BARASCH, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
-
Patent number: 7776824Abstract: Use of neutrophil gelatinase-associated lipocalin (NGAL) as a therapeutic and in a method of treating, reducing, or ameliorating an injury selected from an ischemic injury, an ischemic-reperfusion injury, and a toxin-induced injury, to an organ in a patient. The invention includes administering to the patient NGAL in an amount effective to treat, reduce or ameliorate ischemic, ischemic-reperfusion, or toxin-induced injury to the organ, such as the kidney. A siderophore can be co-administered with the NGAL. The invention also relates to administering a sideophore to enhance a response to secretion of NGAL following an ischemic or toxin-induced injury to an organ in a patient.Type: GrantFiled: May 6, 2005Date of Patent: August 17, 2010Assignees: The Trustees of Columbia University, Children's Hospital Medical CenterInventors: Jonathan M. Barasch, Prasad Devarajan, Kiyoshi Mori
-
Publication number: 20100184089Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.Type: ApplicationFiled: March 30, 2010Publication date: July 22, 2010Inventors: Jonathan Matthew BARASCH, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
-
Publication number: 20100147003Abstract: A mist atomizer is arranged in a first cooling duct including an outlet for vegetable compartment and an inlet for vegetable compartment. The mist atomizer is arranged near a gap of a lower basket and an upper basket. A refrigerator capable of efficiently collecting transpired moisture from stored food, sufficiently humidifying the interior of the basket, and having higher freshness maintaining property is provided.Type: ApplicationFiled: April 25, 2008Publication date: June 17, 2010Inventors: Yoshihiro Ueda, Tadashi Adachi, Kazuya Nakanishi, Toyoshi Kamisako, Kahoru Tsujimoto, Kenichi Kakita, Tosiaki Mamemoto, Sachiko Kanehara, Kiyoshi Mori
-
Patent number: 7736962Abstract: A junction field effect transistor comprises an insulating layer formed in a substrate. A source region of a first conductivity type is formed on the insulating layer, and a drain region of the first conductivity type is formed on the insulating layer and spaced apart from the drain region. A channel region of the first conductivity type is located between the source region and the drain region and formed on the insulating layer. A gate region of the second conductivity type surrounds all surfaces of a length of the channel region such that the channel region is embedded within the gate region.Type: GrantFiled: January 7, 2009Date of Patent: June 15, 2010Assignee: SuVolta, Inc.Inventor: Kiyoshi Mori